
Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Global Forecast 2024-2030
Description
Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Global Forecast 2024-2030
The Degenerative Disc Disease Market size was estimated at USD 2.02 billion in 2023 and expected to reach USD 2.17 billion in 2024, at a CAGR 7.73% to reach USD 3.41 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Degenerative Disc Disease Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Degenerative Disc Disease Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include AnGes MG, Inc., B. Braun SE, Biopharm GmbH, Cerapedics Inc., DePuy Synthes by Medical Device Business Services, Inc., Globus Medical Inc., Kolon TissueGene Inc., Lineage Cell Therapeutics, Inc., Medtronic PLC, NLC Ventures Netherlands B.V., Notogen, Inc., Pfizer Inc., Smith & Nephew PLC, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc..
Market Segmentation & Coverage
This research report categorizes the Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product Type
Devices
Cervical Spine
Lumbar Spine
Spinal Fusion
Thoracic Spine
Drugs
Acetaminophen
Muscle Relaxants
NSAIDs
Oral Steroids
Treatment
Artificial Disc Replacement
Cervical Spine
Lumbar Spine
Spinal Fusion
Thoracic Spine
End-Users
Clinics
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Degenerative Disc Disease Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Degenerative Disc Disease Market?
3. What are the technology trends and regulatory frameworks in the Degenerative Disc Disease Market?
4. What is the market share of the leading vendors in the Degenerative Disc Disease Market?
5. Which modes and strategic moves are suitable for entering the Degenerative Disc Disease Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
187 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Degenerative Disc Disease Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising occurrences of degenerative disc disorders
- 5.1.1.2. Increasing preference for non-surgical treatment options
- 5.1.1.3. Availability of conservative therapies such as physical therapy, and pain relievers
- 5.1.2. Restraints
- 5.1.2.1. High cost of degenerative disc disease surgeries
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in degenerative disc disease treatments
- 5.1.3.2. Introduction of robotic technology in surgical procedures
- 5.1.4. Challenges
- 5.1.4.1. Availability of alternative therapies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Degenerative Disc Disease Market, by Product Type
- 6.1. Introduction
- 6.2. Devices
- 6.3.1. Cervical Spine
- 6.3.2. Lumbar Spine
- 6.3.3. Spinal Fusion
- 6.3.4. Thoracic Spine
- 6.3. Drugs
- 6.4.1. Acetaminophen
- 6.4.2. Muscle Relaxants
- 6.4.3. NSAIDs
- 6.4.4. Oral Steroids
- 7. Degenerative Disc Disease Market, by Treatment
- 7.1. Introduction
- 7.2. Artificial Disc Replacement
- 7.3. Cervical Spine
- 7.4. Lumbar Spine
- 7.5. Spinal Fusion
- 7.6. Thoracic Spine
- 8. Degenerative Disc Disease Market, by End-Users
- 8.1. Introduction
- 8.2. Clinics
- 8.3. Hospitals
- 9. Americas Degenerative Disc Disease Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Degenerative Disc Disease Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Degenerative Disc Disease Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AnGes MG, Inc.
- 13.1.2. B. Braun SE
- 13.1.3. Biopharm GmbH
- 13.1.4. Cerapedics Inc.
- 13.1.5. DePuy Synthes by Medical Device Business Services, Inc.
- 13.1.6. Globus Medical Inc.
- 13.1.7. Kolon TissueGene Inc.
- 13.1.8. Lineage Cell Therapeutics, Inc.
- 13.1.9. Medtronic PLC
- 13.1.10. NLC Ventures Netherlands B.V.
- 13.1.11. Notogen, Inc.
- 13.1.12. Pfizer Inc.
- 13.1.13. Smith & Nephew PLC
- 13.1.14. Ulrich Medical USA Inc.
- 13.1.15. Zimmer Biomet Holdings Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
- FIGURE 2. DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
- FIGURE 3. DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DEGENERATIVE DISC DISEASE MARKET DYNAMICS
- FIGURE 7. DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
- FIGURE 8. DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 10. DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
- FIGURE 12. DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.